EVALUATION OF PREDICTORS OF ARRHYTHMIA IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS

Main Article Content

Alireza Saegh
Seyedehsepideh Ghadirnezhadshiadeh
Bahare Kasaei
Melina Barahouei Moghaddam
Elaheh Mearaji
Mahdi Azadmanesh
Asma Hatami
Noushin Mashatan
Morteza Pishdadian
Ali Maleki
Mohammad Motazed Keivani
Seyed Abbas Pakmehr
Mahdi Zarei

Keywords

HCM, ventricular arrhythmia, ICD

Abstract

Introduction: Hypertrophic cardiomyopathy (HCM) is a condition in which part of the heart becomes thick (hypertrophy) for no apparent reason. Ventricular (fibrillation and ventricular tachycardia) and supraventricular (AF) arrhythmias are common in these patients. This study was performed to evaluate and evaluate the electrocardiographic and echocardiographic factors associated with arrhythmia in HCM patients referred to the Rajaei Heart Center undergoing ICD implantation in patients with sudden arrhythmia (SCD), stroke, and exacerbation of heart failure. Taken is designed.


Materials and Methods: The present study is a descriptive-analytical study that was performed on patients of Rajaei Heart Center with the diagnosis of HCM for whom a cardiac device was implanted. The variables studied in this study included age, sex, type of clinical manifestation of HCM, family history of sudden death, patient's underlying electrocardiographic findings, recorded patient arrhythmias, patient echocardiographic findings, and type and number of patient ICD treatments including shock and ATP. Finally, the data were entered into SPSS software and analyzed. A significance level of 5% was considered for all analyzes.


Results: In the present study, out of 116 patients, 62 were male and 54 were female. The age range of patients was 20 to 87 years and the mean age of patients was 50.4 14 14 years. In the present study, there was a significant relationship between atrial fibrillation and mean ventricular thickness (P = 0.007) and left ventricular size (P = 0.04). In addition, there was no significant relationship between EF and ventricular arrhythmia (P = 0.57) but there was a significant relationship between EF and atrial fibrillation (P = 0.02).


 Conclusion: In the present study, no factor was found that could significantly predict ventricular and supraventricular arrhythmias. In contrast, ventricular arrhythmias may be more common at older ages, with greater LV size, lower EF, and the presence of large, deep inverted TS.


 

Abstract 213 | pdf Downloads 33 pdf Downloads 24

References

1. Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ. Predictors of atrial fibrillation in hypertrophic cardiomyopathy. Heart. 2017 May 1;103(9):672-8.
2. Masri A, Kanj M, Thamilarasan M, Wazni O, Smedira NG, Lever HM, Desai MY. Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis. Cardiovascular diagnosis and therapy. 2017 Feb;7(1):36.
3. Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, Rastegar H, Estes NM, Maron MS, Maron BJ. Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy. Circulation. 2017 Dec 19;136(25):2420-36.
4. van Velzen HG, Theuns DA, Yap SC, Michels M, Schinkel AF. Incidence of device-detected atrial fibrillation and long-term outcomes in patients with hypertrophic cardiomyopathy. The American journal of cardiology. 2017 Jan 1;119(1):100-5.
5. Guttmann OP, Rahman MS, O'Mahony C, Anastasakis A, Elliott PM. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart. 2014 Mar 15;100(6):465-72.
6. Garg L, Gupta M, Sabzwari SR, Agrawal S, Agarwal M, Nazir T, Gordon J, Bozorgnia B, Martinez MW. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management. Heart failure reviews. 2019 Mar;24(2):189-97.
7. Lee SE, Park JK, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B. Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy. Heart. 2017 Oct 1;103(19):1496-501.
8. McClelland S, O’Connor SA, Donohue S, Lavelle L, McErlean A, Dodd JD, Meaney J, McCreery CJ, McDonald K, Quinn M, Erwin JE. Prevalence and impact of atrial fibrillation in a cohort of patients with hypertrophic cardiomyopathy in Ireland. J Atr Fibrillation. 2020;13:37-43.
9. Kwon DH, Setser RM, Popovic ZB, Thamilarasan M, Sola S, Schoenhagen P, et al. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. The international journal of cardiovascular imaging. 2008;24(6):617-25.
10. Siontis KC, Geske JB, Ong K, Nishimura RA, Ommen SR, Gersh BJ. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. Journal of the American Heart Association. 2014;3(3):e001002.
11. Losi MA, Betocchi S, Aversa M, Lombardi R, Miranda M, D'Alessandro G, et al. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. The American journal of cardiology. 2004;94(7):895-900.
12. Siontis KC, Geske JB, Ong K, Nishimura RA, Ommen SR, Gersh BJ. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. Journal of the American Heart Association. 2014;3(3):e001002.
13. Hen Y, Iguchi N, Machida H, Takada K, Utanohara Y, Sumiyoshi T. High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy. Heart and vessels. 2013;28(6):742-9.
14. Kim JW, Pak HN, Park JH, Nam GB, Kim SK, Lee HS, et al. Defibillator electrogram T wave alternans as a predictor of spontaneous ventricular tachyarrhythmias in defibrillator recipients. Circulation journal: official journal of the Japanese Circulation Society. 2009;73(1):55-62.
15. Nagai T, Kurita T, Satomi K, Noda T, Okamura H, Shimizu W, et al. QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy. Circulation journal: official journal of the Japanese Circulation Society. 2009;73(6):1028-32.
16. Candan O, Gecmen C, Kalayci A, Bayam E, Guner A, Gunduz S, et al. Left ventricular twist in hypertrophic cardiomyopathy: Predictor of nonsustained ventricular tachycardia. Herz. 2017.
17. Debonnaire P, Thijssen J, Leong DP, Joyce E, Katsanos S, Hoogslag GE, et al. Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients. The international journal of cardiovascular imaging. 2014;30(3):549-58.
18. Wen SN, Liu N, Li SN, Wu XY, Salim M, Kang JP, et al. QTc Interval Prolongation Predicts Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. Circulation journal : official journal of the Japanese Circulation Society. 2015;79(5):1024-30.
19. Miorelli M, Buja G, Melacini P, Fasoli G, Nava A. QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest. International journal of cardiology. 1994;45(2):121-7.
20. Kwon DH, Setser RM, Popovic ZB, Thamilarasan M, Sola S, Schoenhagen P, et al. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. The international journal of cardiovascular imaging. 2008;24(6):617-25.
21. Terai H, Shimizu M, Ino H, Yamaguchi M, Hayashi K, Sakata K, et al. Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 2003;10(3):304-10.
22. Fakhrioliaei A, Abedinifar F, Salehi Darjani P, Mohammadi-Khanaposhtani M, Larijani B, Ahangar N, Mahdavi M. Hybridization of the effective pharmacophores for treatment of epilepsy: design, synthesis, in vivo anticonvulsant activity, and in silico studies of phenoxyphenyl-1, 3, 4-oxadiazole-thio-N-phenylacetamid hybrids. BMC chemistry. 2023 Jul 17;17(1):80.
23. Mollazadeh M, Azizian H, Fakhrioliaei A, Iraji A, Avizheh L, Valizadeh Y, Zomorodian K, Elahi F, Moazzam A, Kazemzadeh H, Amanlou M. Different barbiturate derivatives linked to aryl hydrazone moieties as urease inhibitors; design, synthesis, urease inhibitory evaluations, and molecular dynamic simulations. Medicinal Chemistry Research. 2023 May;32(5):930-43.
24. Safapoor S, Halimi M, Ghomi MK, Noori M, Dastyafteh N, Javanshir S, Hosseini S, Mojtabavi S, Faramarzi MA, Nasli-Esfahani E, Larijani B. Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline–quinazolinone–thioacetamides. RSC Advances. 2023;13(28):19243-56.
25. Ghalehbandi M, Khosravifar S, Aloosh O, Rahimi‐Golkhandan A, Abounoori M, Aloosh A, Afshar H, Khosravifar S. The association between sleep quality, health status and disability due to breathlessness in chronic obstructive pulmonary disease patients. The Clinical Respiratory Journal. 2021 Nov;15(11):1168-74.
26. Omranifard V, Abounoori M, Babakhanian M, Ebrahimi A, Akouchekian S, Shafiei K, Khosravifar S. Translation and psychometric properties of the Persian version of the Health of the Nation Outcome Scales for Elderly People (HoNOS65+). Aging Medicine. 2021 Jun;4(2):135-45.
27. Zhang L, Pakmehr SA, Shahhosseini R, Hariri M, Fakhrioliaei A, Karkon Shayan F, Xiang W, Karkon Shayan S. Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment. Medical Oncology. 2023 Dec 8;41(1):8.
28. Shayan SK, Nasrollahi E, Bahramvand Y, Zarei M, Atarodi A, Farsi Y, Tavakolizadeh M, Shirvaliloo M, Abbasifard M, Jamialahmadi T, Banach M. Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity. Current Medicinal Chemistry. 2023.
29. Karkon-Shayan S, Aliashrafzadeh H, Dianat-Moghadam H, Rastegar-Pouyani N, Majidi M, Zarei M, Bahramvand Y, Babaniamansour S, Jafarzadeh E. Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths. Acta Histochemica. 2023 Aug 1;125(6):152058.
30. Shayan SK, Nasrollahi E, Bahramvand Y, Zarei M, Atarodi A, Farsi Y, Tavakolizadeh M, Shirvaliloo M, Abbasifard M, Jamialahmadi T, Banach M. Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity. Current Medicinal Chemistry. 2024.
31. Babaniamansour S, Atarodi A, Babaniamansour P, Firouzabadi MD, Majidi M, Karkon-Shayan S. Clinical findings and prognosis of COVID-19 patients with benign prostatic hyperplasia: A case series. Journal ISSN. 2021;2766:2276.
32. Ziaee M, Khajavi A, Najafzadeh A, Tavakolizadeh M, Karkon Shayan S. Information Resources Trust and Self-care Behaviors in Prevention of COVID-19 Among Health Workers in Gonabad City, Iran. Journal of Research and Health. 2022 Jan 10;12(1):49-56.
33. Azani A, Omran SP, Ghasrsaz H, Idani A, kadkhodaei Eliaderani M, Peirovi N, Dokhani N, hassan Lotfalizadeh M, mohammadzadeh Rezaei M, shahgholian Ghahfarokhi M, KarkonShayan S. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer. Pathology-Research and Practice. 2023 Jun 13:154618.
34. Shayan SK, Aliashrafzadeh H, Rezayitalab F, Sobhani M, Zarei M. Comparison of the Outcome of Altplas Administration after Acute Ischemic Stroke in Patients Over 80 Years and Under 80 Years Admitted. Journal of Pharmaceutical Negative Results. 2022 Sep 22:684-8.
35. Ghamari N, Ghaderpanah R, Sadrian SH, Fallah N. Effect of a visual dual task on postural stability—a comparative study using linear and nonlinear methods. Health Sci Rep. 2023; 6:e1437.
36. Tahmasbi F, Mosaddeghi-Heris R, Soleimanzadeh F, Ghaderpanah R, Sadrian S, Hajebrahimi S, Salehi-Pourmehr H. Effects of Posterior Tibial Nerve Stimulation on Fecal Incontinence: An Umbrella Review. Neuromodulation: Technology at the Neural Interface. 2023 Jul 16.
37. Tahmasbi F, Ghaderpanah R, Sadrian S, Heris RM, Salehi-Pourmehr H. Effects of Transcutaneous Electrical Nerve Stimulation (TENS) on Chronic Pain in Older Adults: a Systematic Review and Meta-Analysis. Current Physical Medicine and Rehabilitation Reports. 2023 Apr 21:1-2.
38. Ghaderpanah R, Farpour HR, Seifi P, Sadrian S. The Upper Limb Disorders among Schoolteachers Involved in E-learning during the Pandemic of COVID-19: A Cross-Sectional Study. Journal of Biomedical Physics & Engineering. 2023 Apr 2;13.
39. Baghdadi, Taghi MDa; Zafari, Hamidreza MDa; Ghaderpanah, Rezvan MDb; Moharrami, Alireza MDa; Rafati, Amir Ali MDa; Nabian, Mohammad Hossein MDc; Ebrahiminasab, Mehdi MDa; Zargarbashi, Ramin MDd. Clinical and radiological outcomes of lateral column lengthening (LCL) surgery in pediatrics: a cohort study. Annals of Medicine & Surgery ():10.1097/MS9.0000000000000708, July 24, 2023.